New era in liver cancer care: Neddylation-targeted therapies
Liver cancer treatment is entering a transformative phase with the development of neddylation-targeted therapies. These innovative treatments focus on disrupting the neddylation process, a key pathway involved in cancer cell growth and survival. By targeting this mechanism, researchers aim to offer more effective and precise therapies for liver cancer patients. This breakthrough represents a promising step forward in oncology, potentially improving outcomes and expanding treatment options for those affected by one of the deadliest cancers worldwide.